Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03499236 · ClinicalTrials.gov registry record · NA
Reducing Lung CongestIon Symptoms in Advanced Heart Failure
A NA study of Heart Failure, sponsored by V-Wave.
- Active
- Registry status
- NA
- Development phase
- 605
- Enrollment target
- 20
- Study locations
NCT03499236 is a NA study of Heart Failure that is active but no longer recruiting, run by V-Wave. The registered enrollment target is 605 participants, below the 2,048-participant average among 397 other Heart Failure trials with a reported enrollment target (70% lower). The trial reports 20 study locations across 7 states.
The verdict
NCT03499236, a NA study of Heart Failure, is active but no longer recruiting, sponsored by V-Wave.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 605 participants
- Enrollment target
- 20
- Study locations
Study Summary
The objective of the RELIEVE-HF study is to provide reasonable assurance of safety and effectiveness of the V-Wave Interatrial Shunt System by improving meaningful clinical outcomes in patients with New York Heart Association (NYHA) functional Class II, Class III, or ambulatory Class IV heart failure (HF), irrespective of left ventricular ejection fraction, who at baseline are treated with guideline-directed drug and device therapies.
Conditions Studied
Interventions
- OTHER Control
- DEVICE V-Wave Interatrial Shunt
Study Locations (20)
California
- Scripps Health - La Jolla
- Long Beach Memorial Medical Center - Long Beach
- Keck Medical Center of USC - Los Angeles
- Cedars Sinai Medical Center - Los Angeles
- Kaiser Permanente San Francisco - San Francisco
- University of California, San Francisco - San Francisco
- Stanford Hospital - Stanford
- Los Robles Hospital & Medical Center - Thousand Oaks
- The Lundquist Institute (Harbor-UCLA) Medical Center - Torrance
Florida
- Memorial Hospital - Jacksonville
- University of Miami - Miami
- First Coast Cardiovascular Institute - Orange Park
Arizona
- Abrazo Arizona Heart Hospital - Phoenix
- Arizona Heart Rhythm Center - Phoenix
Georgia
- Piedmont Hospital - Atlanta
- Northeast Georgia Medical Center - Gainesville
Illinois
- Rush University Medical Center - Chicago
- Midwest Cardiovascular Institute - Naperville
Colorado
- South Denver Cardiology - Littleton
Kentucky
- St Elizabeth Medical Center - Edgewood
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 605 participants |
| Start Date | 2018-09-19 |
| Est. Completion | 2027-10-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03499236
The ClinicalTrials.gov registry entry for NCT03499236 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 605 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,048-participant average among 397 other Heart Failure trials with a reported enrollment target (70% lower). The listed sponsor is V-Wave, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Heart Failure appearing as the primary indexed condition, and to 2 interventions - of which Control is the first listed.
NCT03499236 reports 20 study locations spanning 7 distinct geographic areas - top geographies include California, Florida, Arizona.
Frequently Asked Questions
What is clinical trial NCT03499236 about?
NCT03499236 is a clinical study titled "Reducing Lung CongestIon Symptoms in Advanced Heart Failure". The objective of the RELIEVE-HF study is to provide reasonable assurance of safety and effectiveness of the V-Wave Interatrial Shunt System by improving meaningful clinical outcomes in patients with New York Heart Association (NYHA) functional Class II, Class III, or ambulatory Class IV heart failur...
What is the current status of trial NCT03499236?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 605 participants. The study started on 2018-09-19. Estimated completion is 2027-10-31.
What conditions does trial NCT03499236 study?
This clinical trial studies the following conditions: Heart Failure.
What interventions are being tested in trial NCT03499236?
The interventions under investigation include: Control (OTHER), V-Wave Interatrial Shunt (DEVICE).
Who is sponsoring clinical trial NCT03499236?
This trial is sponsored by V-Wave, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03499236 being conducted?
This trial has 20 study locations across Arizona, California, Colorado, Florida, Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Heart Failure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Early Feasibility Study of the NORM™ System in Heart Failure Patients (FUTURE-HFII)
RECRUITING · NA
-
Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
RECRUITING · NA
-
iCardia4HF: Multi-component mHealth Intervention for Patients With Heart Failure
RECRUITING · NA
-
Optimizing Heart Failure Therapies Among Patients With Limited Access in Denver
RECRUITING · NA
-
Hemodynamic Monitoring to Prevent Adverse Events foLlowing cardiOgenic Shock Trial
RECRUITING · NA
-
Effect of a Quality Improvement Initiative to Address Social Determinants of Health on Rehospitalization Rates in Patients With Heart Failure
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.